Company Filing History:
Years Active: 2011-2013
Title: Ryan Blair Rountree: Innovator in Cancer Treatment
Introduction
Ryan Blair Rountree is an accomplished inventor based in San Jose, CA. He has made significant contributions to the field of cancer treatment, particularly through his innovative use of recombinant MVA viruses. With a total of 2 patents, Rountree's work focuses on advancing therapeutic methods for prostate cancer.
Latest Patents
Rountree's latest patents include the use of MVA to treat prostate cancer. This invention relates to compositions, kits, and methods for cancer prophylaxis and therapy using recombinant MVA viruses that encode tumor-associated antigens, such as PSA and PAP. The recombinant MVA viruses are designed to induce both B- and T-cell responses. Furthermore, these viruses can be administered prior to, simultaneously with, or after a taxane treatment.
Career Highlights
Throughout his career, Rountree has worked with notable companies in the biotechnology sector, including Bn Immunotherapeutics, Inc. and Bavarian Nordic A/S. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer therapy.
Collaborations
Rountree has collaborated with esteemed colleagues such as Alain Delcayre and Reiner Laus. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Ryan Blair Rountree is a notable inventor whose work in cancer treatment showcases the potential of innovative therapies. His contributions to the field are paving the way for new approaches to combat prostate cancer effectively.